<DOC>
	<DOC>NCT00440011</DOC>
	<brief_summary>Patients with glaucoma or ocular hypertension currently being treated with latanoprost 0.005%, and in need of additional IOP lowering, will be randomized to receive either bimatoprost 0.03% or travoprost 0.004% in place of latanoprost 0.005%</brief_summary>
	<brief_title>Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Glaucoma or ocular hypertension in both eyes Currently being treated with latanoprost 0.005% daily and in need of additional IOPlowering Bestcorrected visual acuity of 20/100 or better in each eye Visual field within 6 months of study entry Secondary glaucoma Active intraocular inflammation or macular edema Intraocular surgery or laser surgery within the past 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>